Yutang Ren1, Xiaowei Tang2,3, Yanmin Chen4, Fengping Chen2, Yingying Zou2, Zhiliang Deng2, Jianuan Wu2, Yan Li4, Silin Huang2, Bo Jiang1, Wei Gong5. 1. Department of Gastroenterology, Beijing Tsinghua Changgung Hospital, Medical Center, Tsinghua University, Beijing, China. 2. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 3. Department of Gastroenterology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, China. 4. Department of Gastroenterology, First People's Hospital of Yunnan Province, Kunming, China. 5. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China. drgwei@foxmail.com.
Abstract
BACKGROUND: Peroral endoscopic myotomy (POEM) is a novel treatment for achalasia with excellent outcomes. But the predictor for treatment failure is not well defined. This study was aimed to prospectively investigate the factors for predicting failed POEM. METHODS: From June 2011 to May 2015, a total of 115 achalasia patients treated by POEM were included for the retrospective cohort study from Nanfang Hospital and the First People's Hospital of Yunnan Province. Patients were followed up with Eckardt score, high-resolution manometry and endoscope. POEM failure was defined as primary failure (Eckardt score failed to decrease to 3 or below) and recurrences (decrease of Eckardt score to 3 or below, then rise to more than 3) during one-year follow-up. Univariate and multivariate Cox regression analyses were performed to assess the predictive factor. For the associated factor, receiver operating characteristic curve (ROC) was utilized to determine the cutoff value of the predicting factor. RESULTS: The failure rate of POEM after 1 year was 7.0% (8/115), including 5 primary failure cases and 3 recurrences. Multivariate analysis showed higher pre-treatment Eckardt score was the single independent factor associated with POEM failure [9.5 (6-12) vs. 7 (2-12), odds ratio (OR) 2.24, 95 confidence interval (95% CI) 1.39-3.93, p = 0.001]. The cutoff value (Eckardt score ≥9) had 87.5 sensitivity (95% CI 47.3-99.7%) and 73.8% specificity (95% CI 64.4-81.9%) for predicting failed POEM. CONCLUSIONS: Pre-treatment Eckardt score could be a predictive factor for failed POEM. Eckardt score ≥9 was associated with high sensitivity and specificity for predicting POEM failure.
BACKGROUND: Peroral endoscopic myotomy (POEM) is a novel treatment for achalasia with excellent outcomes. But the predictor for treatment failure is not well defined. This study was aimed to prospectively investigate the factors for predicting failed POEM. METHODS: From June 2011 to May 2015, a total of 115 achalasiapatients treated by POEM were included for the retrospective cohort study from Nanfang Hospital and the First People's Hospital of Yunnan Province. Patients were followed up with Eckardt score, high-resolution manometry and endoscope. POEM failure was defined as primary failure (Eckardt score failed to decrease to 3 or below) and recurrences (decrease of Eckardt score to 3 or below, then rise to more than 3) during one-year follow-up. Univariate and multivariate Cox regression analyses were performed to assess the predictive factor. For the associated factor, receiver operating characteristic curve (ROC) was utilized to determine the cutoff value of the predicting factor. RESULTS: The failure rate of POEM after 1 year was 7.0% (8/115), including 5 primary failure cases and 3 recurrences. Multivariate analysis showed higher pre-treatment Eckardt score was the single independent factor associated with POEM failure [9.5 (6-12) vs. 7 (2-12), odds ratio (OR) 2.24, 95 confidence interval (95% CI) 1.39-3.93, p = 0.001]. The cutoff value (Eckardt score ≥9) had 87.5 sensitivity (95% CI 47.3-99.7%) and 73.8% specificity (95% CI 64.4-81.9%) for predicting failed POEM. CONCLUSIONS: Pre-treatment Eckardt score could be a predictive factor for failed POEM. Eckardt score ≥9 was associated with high sensitivity and specificity for predicting POEM failure.
Authors: Yuki B Werner; Guido Costamagna; Lee L Swanström; Daniel von Renteln; Pietro Familiari; Ahmed M Sharata; Tania Noder; Guido Schachschal; Jan F Kersten; Thomas Rösch Journal: Gut Date: 2015-04-30 Impact factor: 23.059
Authors: Mouen A Khashab; Ahmed A Messallam; Manabu Onimaru; Ezra N Teitelbaum; Michael B Ujiki; Matthew E Gitelis; Rani J Modayil; Eric S Hungness; Stavros N Stavropoulos; Mohamad H El Zein; Hironari Shiwaku; Rastislav Kunda; Alessandro Repici; Hitomi Minami; Philip W Chiu; Jeffrey Ponsky; Vivek Kumbhari; Payal Saxena; Amit P Maydeo; Haruhiro Inoue Journal: Gastrointest Endosc Date: 2015-01-26 Impact factor: 9.427
Authors: Lee L Swanstrom; Ashwin Kurian; Christy M Dunst; Ahmed Sharata; Neil Bhayani; Erwin Rieder Journal: Ann Surg Date: 2012-10 Impact factor: 12.969
Authors: John E Pandolfino; Monika A Kwiatek; Thomas Nealis; William Bulsiewicz; Jennifer Post; Peter J Kahrilas Journal: Gastroenterology Date: 2008-07-22 Impact factor: 22.682
Authors: Vivek Kumbhari; Alan H Tieu; Manabu Onimaru; Mohammad H El Zein; Ezra N Teitelbaum; Michael B Ujiki; Matthew E Gitelis; Rani J Modayil; Eric S Hungness; Stavros N Stavropoulos; Hiro Shiwaku; Rastislav Kunda; Philip Chiu; Payal Saxena; Ahmed A Messallam; Haruhiro Inoue; Mouen A Khashab Journal: Endosc Int Open Date: 2015-04-13
Authors: Muhammad B Darwish; Shankar I Logarajah; Kei Nagatomo; Terence Jackson; Annie Laurie Benzie; Patrick James McLaren; Edward Cho; Houssam Osman; D Rohan Jeyarajah Journal: JSLS Date: 2021 Oct-Dec Impact factor: 2.172